Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29246835 | 1.00 | LMNA (0.67) | LMNATSHRTDP1MEN1KMT2A | |
| SCHEMBL2170337 | 1.00 | LMNA (0.67) | LMNATSHRTDP1MEN1KMT2A | |
| SCHEMBL2168536 | 1.00 | LMNA (0.67) | LMNATSHRTDP1MEN1KMT2A | |
| SCHEMBL2166576 | 0.86 | LMNA (0.50) | LMNATSHRTDP1MEN1KMT2A | |
| SCHEMBL2166578 | 0.86 | LMNA (0.50) | LMNATSHRTDP1MEN1KMT2A | |
| SCHEMBL2169791 | 0.86 | LMNA (0.50) | LMNATSHRTDP1MEN1KMT2A | |
| SCHEMBL3696141 | 0.84 | LMNA (0.49) | LMNATSHRHTTKDM4EALDH1A1 | |
| SCHEMBL3696144 | 0.84 | LMNA (0.49) | LMNATSHRHTTKDM4EALDH1A1 | |
| SCHEMBL9797004 | 0.84 | LMNA (0.65) | LMNATSHRTDP1MEN1KMT2A | |
| SCHEMBL3683589 | 0.84 | LMNA (0.65) | LMNATSHRTDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030032839-A1 | Process for racemizing optically active vinyl-substituted cyclopropanecarboxylic acid compound | PANASONIC CORPORATION (JP) | 2003-02-13 | — | — | US | claimed |
| EP-1792889-B1 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL CO (JP) | 2015-03-04 | — | — | EP | disclosed |
| EP-1547995-B1 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL CO (JP) | 2014-05-07 | — | — | EP | disclosed |
| EP-1681282-B1 | METHOD FOR PRODUCING 3,3-DIMETHYL-2-(1-PROPENYL) CYCLOPROPANE CARBOXYLATE | SUMITOMO CHEMICAL CO (JP) | 2013-01-23 | — | — | EP | disclosed |
| EP-1970368-B1 | METHOD FOR PRODUCING OLEFIN COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-7985872-B2 | Method for producing olefin compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-26 | — | — | US | disclosed |
| CN-1874990-B | Method for producing 3,3-dimethyl-2-(1-propenyl)cyclopropane carboxylic acid ester | SUMITOMO CHEMICAL CO | 2011-06-29 | — | — | CN | disclosed |
| CN-1934063-B | Method for producing (2-formyl-1-alkenyl)cyclopropane compound | SUMITOMO CHEMICAL CO | 2010-12-15 | — | — | CN | disclosed |
| CN-1660764-B | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL CO | 2010-12-08 | — | — | CN | disclosed |
| US-7741511-B2 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-22 | — | — | US | disclosed |
| US-20050090688-A1 | Metallized mesoporous silicate and method of oxidation with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-04-28 | — | — | US | disclosed |
| EP-1473275-A1 | METALLIZED MESOPOROUS SILICATE AND METHOD OF OXIDATION WITH THE SAME | Sumitomo Chemical Company, Limited (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-20040152592-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMTED | 2004-08-05 | — | — | US | disclosed |
| US-6750370-B2 | CHEMICAL INTERMEDIATE FOR SYNTHETIC PYRETHROIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-06-15 | — | — | US | disclosed |
| US-6703528-B2 | CATALYTIC OXIDATION OF OLEFIN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-03-09 | — | — | US | disclosed |
| EP-1377584-A1 | NOVEL CYCLOHEXENYL PHENYL DIAZEPINES AS VASOPRESSIN AND OXYTOCIN RECEPTOR MODULATORS | Wyeth (US) | 2004-01-07 | — | — | EP | disclosed |
| US-20030032839-A1 | Process for racemizing optically active vinyl-substituted cyclopropanecarboxylic acid compound | PANASONIC CORPORATION (JP) | 2003-02-13 | — | — | US | disclosed |
| WO-2002083681-A1 | NOVEL CYCLOHEXENYL PHENYL DIAZEPINES VASOPRESSIN AND OXYTOCIN RECEPTOR MODULATORS | WYETH (US) | 2002-10-24 | — | — | WO | disclosed |
| EP-1188735-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-03-20 | — | — | EP | disclosed |
| US-20020025906-A1 | Process for producing carbonyl or hydroxy compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032839-A1 | Process for racemizing optically active vinyl-substituted cyclopropanecarboxylic acid compound | NOS1, CYP1B1, CBR1 | LMNA 2790/4885TSHR 3624/4885TDP1 2736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.